DAPHNE FOUST: Open Payments
NPI 1699742205 · PARIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 17 payments from 5 companies in 2025. Trend: 2023 $262 · 2024 $533 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $159 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| Lilly USA, LLC | 1 | $22 |
| ABBVIE INC. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: CAPLYTA, FANAPT, KISUNLA, VRAYLAR, Auvelity.
Industry payments across TN — which companies pay providers there.
